Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help? - Wikidata - awgldk - TriplyDB

Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?

Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?

http://www.wikidata.org/entity/Q37033834

about

Maternal buprenorphine treatment and infant outcome.

P2860

Q47712360-A3B80406-7717-4B9E-A5FE-D7C2C2AC6EDD

P2860

Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?

http://www.wikidata.org/entity/Q37033834

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predictors of neonatal abstine ...... rphine metabolite levels help?

@en

Predictors of neonatal abstine ...... rphine metabolite levels help?

@nl

type

label

Predictors of neonatal abstine ...... rphine metabolite levels help?

@en

Predictors of neonatal abstine ...... rphine metabolite levels help?

@nl

prefLabel

Predictors of neonatal abstine ...... rphine metabolite levels help?

@en

Predictors of neonatal abstine ...... rphine metabolite levels help?

@nl

P1433

Q37033834-D5FEA6FE-0A15-4FE0-9505-A94F7CB078DB

P1476

Q37033834-9FE04082-5C83-4C52-9BDC-582B044F7769

P2093

Q37033834-0F55569C-0560-495E-92A0-20823BA830AF

Q37033834-246D1D6F-AB42-4A2F-B9B0-8E5883DC7CFE

Q37033834-2D30EA92-5607-421E-88BF-80BC13F6337F

Q37033834-56E6B4DF-13ED-44E8-A1FE-B402DE905EC0

Q37033834-7071A6DC-2CF9-449B-B4B6-F048E1CB9D4F

Q37033834-80180FD9-A46A-4B59-A951-DEA1F715454B

Q37033834-86B9A8A4-4D3E-41D5-88B7-41FFEFAEF682

Q37033834-DF7D6E48-307E-41A2-96C1-35997917A69F

P2860

Q37033834-0325303E-A7E6-43A7-B683-B55D6E2E685D

Q37033834-037E9DD3-04DD-440F-B581-A1A0B7432744

Q37033834-061BC3C3-31F0-4606-A745-2B34E0026BF2

Q37033834-082904D8-87A5-475D-8A59-1387D388165C

Q37033834-0FFF0D58-16D5-4770-A399-9036C5F74BFC

Q37033834-127F852C-1710-4CBC-9D50-07FA60F3E2CC

Q37033834-12A61838-2F62-400C-A532-3E8B1E6FC9E0

Q37033834-2194A6E8-49F8-45C1-B19B-696DEF53F1E3

Q37033834-2333FE43-8362-4041-B09D-FD50EFAE6AB8

Q37033834-346E5625-AB67-4193-AB04-E73849DBD3CB

P2888

Q37033834-3221D7F3-E34F-4E61-A9BE-6C9DE8A18D74

P304

Q37033834-4D50757E-75F1-4320-9AF2-B5B3E20BCD83

P31

Q37033834-5EDCB800-66DD-4080-A50A-645AC3FC66B0

P356

Q37033834-AEF776C9-C88B-4ABA-8DF3-9D64FD4A2899

P433

Q37033834-3F193B11-5E7F-48F4-B79F-5D87DD3CDF0F

P478

Q37033834-09CA7E04-CE65-4A09-93B4-7466E623231C

P577

Q37033834-1B99E17A-C78B-427C-9089-4521BFBE2D8A

P6179

Q37033834-9F9CA415-B1D7-4009-84E5-08D063C73D0A

P698

Q37033834-7809870E-6F53-4EBD-B447-43072A0BF460

P932

Q37033834-67AA45E1-1521-4A43-9F5A-C5D84825C07B

P356

S40064-016-2576-8

P1433

P1476

Predictors of neonatal abstine ...... rphine metabolite levels help?

@en

P2093

Amy Kyle

http://www.w3.org/2001/XMLSchema#string

Darshan Shah

http://www.w3.org/2001/XMLSchema#string

Jason Pryor

http://www.w3.org/2001/XMLSchema#string

Nick Hagemeier

http://www.w3.org/2001/XMLSchema#string

Nilesh Dankhara

http://www.w3.org/2001/XMLSchema#string

Piyuesh Singh

http://www.w3.org/2001/XMLSchema#string

Shimin Zheng

http://www.w3.org/2001/XMLSchema#string

Stacy Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence

Neonatal abstinence syndrome after methadone or buprenorphine exposure

Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.

Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.

Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes.

Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.

Estrogen-related receptor gamma (ERRgamma) mediates oxygen-dependent induction of aromatase (CYP19) gene expression during human trophoblast differentiation.

Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.

P2888

s40064-016-2576-8

P304

854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-016-2576-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036092768

http://www.w3.org/2001/XMLSchema#string

P698

27386303

http://www.w3.org/2001/XMLSchema#string

P932

4919189

http://www.w3.org/2001/XMLSchema#string